Medical News

RSS

Perinatal exposure to BPA affects mammary hormone response

A recent study accepted for publication in Molecular Endocrinology, a journal of The Endocrine Society, found that perinatal exposure to environmentally relevant doses of bisphenol A (BPA) alters long-term hormone response and breast development in mice that may increase the propensity to develop cancer.

3 Oct 2011

Emergent BioSolutions receives $1.25B contract to supply 44.75M doses of BioThrax

Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.

3 Oct 2011

Mayo Clinic expands Medical School to Arizona

Mayo Clinic announced the expansion of Mayo Medical School in Rochester, Minnesota, to Arizona, creating a branch to be called Mayo Medical School -- Arizona Campus.

3 Oct 2011

Dosing commences in Auxilium's XIAFLEX phase IIIb trial for Dupuytren's contracture

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced that the first patients have been dosed in the Company's phase IIIb trial of XIAFLEX® for the treatment of adult Dupuytren's contracture patients with multiple palpable cords.

3 Oct 2011

Florida AHCA renews Medicaid Management Information System service agreement with HP

HP Enterprise Services today announced the Florida Agency for Health Care Administration (AHCA) has signed a renewal service agreement to manage the state's Medicaid Management Information System.

3 Oct 2011

Potential new drug could treat mixed-lineage leukaemia

A team lead by Cancer Research UK scientists have shown that a potential new drug could treat mixed-lineage leukaemia (MLL), the most common form of leukaemia in babies, according to a study published in Nature today.

3 Oct 2011

GeoVax completes enrollment for HIV/AIDS vaccine Phase 2a clinical trial

GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today the completion of enrollment for a Phase 2a clinical trial testing its HIV/AIDS vaccine.

3 Oct 2011

First Edition: October 3, 2011

Today's headlines include stories previewing how health policy issues will fit into the Supreme Court's new term.

3 Oct 2011

NHI partners with Polaris Hospital affiliates to develop acute care hospital in Murfreesboro

National Health Investors, Inc. announced today it has entered into a development and lease transaction with affiliates of Polaris Hospital Company to develop a 60-bed general acute care hospital in Murfreesboro, Tennessee that will provide acute psychiatric and in-patient rehabilitation services. NHI's total commitment to the project is $21.5 million.

3 Oct 2011

New data on long-term use of antidepressant drugs

There is increasing awareness that, in some cases, long-term use of antidepressant drugs (AD) may enhance the biochemical vulnerability to depression and worsen its long-term outcome and symptomatic expression, decreasing both its likelihood of subsequent response to pharmacological treatment and the duration of symptom-free periods. A review of literature suggesting potential side effects during long treatment with antidepressant drugs was performed.

3 Oct 2011

MEDNAX acquires maternal-fetal medicine physician group practice in St. Louis, MO

MEDNAX, Inc., today announced the acquisition of a maternal-fetal medicine physician group practice based in St. Louis, MO.

3 Oct 2011

Health Canada approves Trajenta (linagliptin) for type 2 diabetes

Boehringer Ingelheim Canada and Eli Lilly Canada today announced that Health Canada has approved Trajenta (linagliptin), a new oral therapy to improve glycemic control in Canadian adults with type 2 diabetes.

3 Oct 2011

OCM announces acquisition of RIN

One Call Medical, Inc. (OCM), the nation's leading provider of specialty services to insurance payers, today announced its acquisition of Raytel Imaging Network, Inc. (RIN), a preferred provider network of diagnostic imaging services, including MRIs and CT scans. This acquisition expands and strengthens OCM's market-leading national diagnostic network.

3 Oct 2011

Alkermes initiates ALKS 37 phase 2b study in opioid-induced constipation

Alkermes plc today announced the initiation of a phase 2b study of ALKS 37, an orally active, peripherally restricted opioid antagonist for the treatment of opioid-induced constipation.

3 Oct 2011

Study sheds new light on relationship of anxiety and high blood pressure to primary aldosteronism

A study that has been published in the Journal of Clinical Endocrinology and Metabolism by an Italian group headed by Nicoletta Sonino (Padova) sheds some new light on the relationship of anxiety and high blood pressure to a hormonal disturbance, primary aldosteronism.

3 Oct 2011

GETINGE to acquire Atrium Medical

Atrium Medical Corporation, announced today that it has signed a definitive agreement to be acquired by GETINGE GROUP of Sweden and its subsidiary, MAQUET Cardiovascular, a global leading provider of cardiovascular technologies for $680 million.

3 Oct 2011

La Jolla Institute scientist identifies previously unknown T cell interaction

Most of the time, the immune system is the body's protector, warding off invading viruses and bacteria before they can lead to infection and disease. But in autoimmune diseases, the immune system does an about face, turning on the body and attacking normal cells.

3 Oct 2011

Vexim obtains registration certificate for SpineJack in India

Vexim, the Med-Tech specialist in the minimally invasive, anatomical treatment of vertebral compression fractures, today announced that it has obtained the registration certificate for SpineJack in India.

3 Oct 2011

Mild stroke patients may live with hidden disabilities: Study

On the surface they appear unaffected, but people who have mild strokes may live with hidden disabilities, including depression, vision problems and difficulty thinking, according to a study released today at the Canadian Stroke Congress.

3 Oct 2011

New research uses Tilman model to study metastasis of prostate cells into bone

The invasion of a new species into an established ecosystem can be directly compared to the steps involved in cancer metastasis. New research published in BioMed Central's open access journal Theoretical Biology and Medical Modelling uses the Tilman model of competition between invasive species to study the metastasis of prostate cells into bone.

3 Oct 2011